Marginal Revolution has a post by Alex Tabborok on pharmaceuticals, linking to a recent New Yorker piece by Malcolm Gladwell.

One key point of both: U.S. prices are actually lower than prices in other nations for drugs that are off-patent because competition from generics keeps the price down. Few who favor re-importation would be willing to give up this part of our system.